Researchers from Griffith University’s National Centre for Neuroimmunology and Emerging Diseases (NCNED) have made a groundbreaking discovery that could bring...
People with Long COVID in Australia have poor health outcomes that are comparable with another emerging disease known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.
Calls for new national clinical guidelines to improve the care of hundreds of thousands of Australians with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and potentially thousands more with Long Covid.
Griffith University’s research into the potential overlap between Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has received a major boost thanks to a $6.4 million grant from the Stafford Fox Medical Research Foundation.
Three Griffith University research projects have been successful in gaining grants from the Medical Research Future Fund (MRFF).
A video game featuring a mystical character named Rumble has helped Griffith University researchers investigate how school kids fared following lockdown disruption.
In a world-first, Griffith University researchers have used an ultra-high field MRI (7 Tesla) to investigate how COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) mirror the same effects on the brain structure.
Dr Sarah D’Arcy, Dr Chester Cao, Dr Steve Ahn, and Dr Victoria Allan along with their supervisor Associate Professor Alireza Ahmadvand investigated how the COVID-19 pandemic and associated lockdowns affected rates of long-acting reversible contraception utilisation.
Academics from the Griffith Asia Institute (GAI) collaborated with researchers from the Indo-Pacific to examine the risks related to economic...
